Companies /Healthcare

Equillium Inc

NASDAQ: EQ Biotechnology
$2.22
▼ $0.05 (−2.20%) today
Markets open · 2:51pm ET
Today · % change

Fundamentals

Market Cap
$143.9M
Revenue (TTM)
$4.4M
EPS (TTM)
$-0.09
52-Week Range
$1 – $4
Street Target
$8.56

About Equillium

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory disorders with unmet medical needs. The company is headquartered in La Jolla, California.

EQ Coverage